Aster DM Healthcare Share Price Target 2025, 2026, 2030, 2040, 2050
Aster DM Healthcare is a large healthcare company that was started by Dr. Azad Moopen. It began as a small clinic in Dubai and has grown into a big network of hospitals and clinics. The main office is in Dubai, and it is officially registered in Bengaluru, India. It runs hospitals, clinics, labs, pharmacies, and testing centres under names like ASTER, MEDCARE, and ACCESS, serving people from all income levels. The company focuses on giving good care to patients using modern technology and experienced doctors and nurses. In India, it has many hospitals and clinics in different states.
- 1 What is Aster DM Healthcare Ltd. NSE: ASTERDM?
- 2 Share Price Target Tomorrow
- 3 Aster DM Healthcare Share price Target 2025
- 4 Aster DM Healthcare Share Price Target 2026
- 5 Share price Target 2027
- 6 Share price Target 2028
- 7 Share price Target 2029
- 8 Aster DM Healthcare share price Target 2030
- 9 Share price Target 2040
- 10 Share Price Target 2050
- 11 Should I buy Aster DM Healthcare stock?
- 12 Aster DM Healthcare earnings results
- 13 Is Aster DM Healthcare stock good to buy? (bull case & bear case)
- 14 Conclusion
- 15 FAQs
What is Aster DM Healthcare Ltd. NSE: ASTERDM?
Aster DM Healthcare is a big healthcare company started in 1987 by Dr. Azad Moopen. It is situated in Dubai and is officially registered in Bengaluru, India. It works in both the Middle East and India. The company runs hospitals, clinics, pharmacies, labs, and medical colleges. In India, it has 19 hospitals and plans to expand more, with a goal of having over 13,000 beds by 2027. It also offers online health services. Recently, it made changes by separating its Middle East business and joining its India business with another company.
The stock has reached its all-time high price, which shows that the company is doing good business. Before the bullish trend, the stock had fallen much. But it took support from its daily time frame and has continuously shown a strong bullish move. Well, to buy this stock, you should wait for the price to approach its nearest support level because the stock is at its all-time high price. So wait to become the stock to get more profits.
Day | Minimum Price (Rs) | Maximum Price (Rs) |
Tomorrow | -18 | +55 |
It works in seven countries: the UAE, India, Oman, Saudi Arabia, Qatar, Bahrain, and Jordan. It offers medical services through many places like hospitals, clinics, test centres, and pharmacies. It has more than 900 medical centres, including over 30 hospitals, 120 clinics, and 450 pharmacies. It has over 32,000 workers, including doctors, nurses, and other healthcare staff. In India, it runs major hospitals in Bengaluru. In the Middle East, it provides care for both wealthy and budget-friendly patients. In 2025, its share price target would be ₹924, as per our analysis.
By our prediction, its share price would be between ₹387 to ₹924 in 2025.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2025 | 387 | 924 |
Month | Minimum Price (Rs) | Maximum Price (Rs) |
January | 466 | 534 |
February | 392 | 496 |
March | 387 | 504 |
April | 450 | 519 |
May | 496 | 609 |
June | 542 | 606 |
July | 561 | 720 |
August | 550 | 756 |
September | 590 | 789 |
October | 652 | 751 |
November | 680 | 830 |
December | 775 | 924 |
It provides all types of medical care in one system, from regular doctor check-ups to serious treatments. This way, patients can receive the service of their whole treatment in a single place. It has big hospitals for major health problems like cancer, heart, brain, and kidney issues. It also has clinics for simple check-ups, pharmacies for easy medicine access, and online services like video doctor visits, health apps, and smart tools to help find problems early. In 2026, its share price target would be ₹1411, as per our prediction.
Its share price would be between ₹820 to ₹1411 in 2026, as per our analysis.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2026 | 820 | 1411 |
Month | Minimum Price (Rs) | Maximum Price (Rs) |
January | 820 | 1010 |
February | 890 | 1057 |
March | 924 | 1074 |
April | 965 | 1120 |
May | 986 | 1157 |
June | 1025 | 1178 |
July | 1058 | 1220 |
August | 1141 | 1268 |
September | 1167 | 1290 |
October | 1186 | 1325 |
November | 1257 | 1365 |
December | 1290 | 1411 |
It uses the latest technology to run hospitals more smoothly. In its main hospitals, it uses special robots to do very exact surgeries for kidney, cancer, and women’s health problems. In 2024, it performed over 1,800 surgeries using these robots, showing its strong medical skills. It also uses smart computer tools like Artificial Intelligence to help with tests, reading scans, and finding which patients need quick care. As it’s an online service, patients can talk to doctors from home, check their health records, and even get care at home. In 2027, its share price target would be ₹1893, as per our analysis.
By our prediction, its share price would be between ₹1290 to ₹1893 in 2027.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2027 | 1290 | 1893 |
It cares a lot about helping people. Their program, Aster Volunteers, has helped over 5.3 million people around the world. They provide free medical care to those who need it most, especially in India, Africa, and the Middle East. They organize free health camps, surgeries, mobile clinics, and teach people about health in poor areas. They have trained more than 276,000 people in basic life-saving skills and helped over 1.4 million people with free care through mobile clinics. In 2028, its share price target would be ₹2387, as per our prediction.
Its share price would be between ₹1790 to ₹2387 in 2028, as per our analysis.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2028 | 1790 | 2387 |
It is known for good medical care in India and the Gulf countries. Their hospitals help people with heart problems, cancer, bone and joint issues, and do organ transplants. In 2024, they did more than 575 organ transplants like liver, kidney, and bone marrow. Aster MIMS in Kozhikode was the first hospital in India to get a special award from the American Heart Association for quick stroke care. Its hospital in Kochi and the heart centre in Bengaluru are known for good care and new ideas. They use advanced machines and robots and follow top safety rules to keep patients healthy. In 2029, its share price target would be ₹2872, as per our analysis.
By our prediction, its share price would be between ₹2230 to ₹2872 in 2029.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2029 | 2230 | 2872 |
It is known that good education is important to provide great healthcare. So, they spend a lot on training and teaching programs. They train doctors, nurses, and other health workers. They also work with schools and medical colleges in India and the UAE to do research and training. In 2022, it opened the Health Academy in Bengaluru. The academy offers courses in management, medical care, and life sciences, mixing classroom lessons with real work experience. In 2030, its share price target would be ₹3395, as per our prediction.
Its share price would be between ₹2800 to ₹3395 in 2030, as per our analysis.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2030 | 2800 | 3395 |
Month | Minimum Price (Rs) | Maximum Price (Rs) |
January | 2800 | 2945 |
February | 2832 | 2968 |
March | 2850 | 2986 |
April | 2878 | 3000 |
May | 2893 | 3024 |
June | 2925 | 3057 |
July | 2950 | 3100 |
August | 2975 | 3134 |
September | 3054 | 3184 |
October | 3085 | 3200 |
November | 3125 | 3275 |
December | 3239 | 3395 |
It has spent a lot of money on building modern hospitals and clinics. In India, it is growing quickly and plans to increase hospital beds from about 5,100 to 6,500. They are using ₹1,900 crore to build new hospitals in smaller cities and make current hospitals bigger. Some important projects are a big 939-bed hospital in Sarjapur, Bengaluru, new hospitals in Trivandrum with 454 beds, Kasaragod with 264 beds, and a 300-bed hospital for women and children in Hyderabad. In 2040, its share price target would be ₹6798, as per our analysis.
By our prediction, its share price would be between ₹6230 to ₹6798 in 2040.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2040 | 6230 | 6798 |
Month | Minimum Price (Rs) | Maximum Price (Rs) |
January | 6230 | 6360 |
February | 6275 | 6389 |
March | 6290 | 6400 |
April | 6312 | 6421 |
May | 6329 | 6440 |
June | 6357 | 6478 |
July | 6384 | 6490 |
August | 6380 | 6530 |
September | 6398 | 6548 |
October | 6424 | 6562 |
November | 6437 | 6600 |
December | 6532 | 6798 |
It always cares about patients. Their hospitals and clinics in India and the Middle East work to give the best care to every patient. They create special treatment plans for each person and talk to patients kindly. They also use easy digital tools like electronic health records, chatbots to help, and mobile apps where patients can book appointments, see test results, and talk to doctors online. Their hospitals follow top global quality rules and have important certificates like JCI and NABH. In 2050, its share price target would be ₹10507, as per our prediction.
Its share price would be between ₹9879 to ₹10507 in 2050, as per our analysis.
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2050 | 9879 | 10507 |
Month | Minimum Price (Rs) | Maximum Price (Rs) |
January | 9879 | 10010 |
February | 9957 | 10090 |
March | 9985 | 10137 |
April | 10090 | 10178 |
May | 10132 | 10232 |
June | 10156 | 10268 |
July | 10167 | 10300 |
August | 10182 | 10354 |
September | 10180 | 10389 |
October | 10200 | 10420 |
November | 10275 | 10465 |
December | 10335 | 10507 |
Should I buy Aster DM Healthcare stock?
Year | Minimum Price (Rs) | Maximum Price (Rs) |
2025 | 387 | 924 |
2026 | 820 | 1411 |
2027 | 1290 | 1893 |
2028 | 1790 | 2387 |
2029 | 2230 | 2872 |
2030 | 2800 | 3395 |
2040 | 6230 | 6798 |
2050 | 9879 | 10507 |
It is growing fast and has many hospitals and clinics in India and the Middle East. They use new technology and plan to add more hospital beds. The company earns good profits and shares some of them with its investors as dividends. But the stock price is currently very high, so it might be expensive to buy right now. It could be a good option for long-term investment if you wait for the price to drop before buying.
Aster DM Healthcare earnings results
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
Sales + | 8,652 | 8,608 | 10,253 | 2,994 | 3,699 | 4,138 |
Expenses + | 7,187 | 7,506 | 8,720 | 2,547 | 3,124 | 3,393 |
Operating Profit | 1,465 | 1,103 | 1,533 | 447 | 575 | 746 |
OPM % | 17% | 13% | 15% | 15% | 16% | 18% |
Other Income + | -158 | 53 | 51 | 353 | 32 | 5,169 |
Interest | 391 | 334 | 307 | 96 | 119 | 124 |
Depreciation | 586 | 618 | 641 | 192 | 220 | 249 |
Profit before tax | 330 | 205 | 637 | 511 | 268 | 5,542 |
Tax % | 5% | 13% | 6% | 7% | 21% | 2% |
Net Profit + | 315 | 178 | 601 | 475 | 212 | 5,408 |
EPS in Rs | 5.54 | 2.96 | 10.53 | 8.51 | 2.59 | 107.66 |
Dividend Payout % | 0% | 0% | 0% | 0% | 77% | 114% |
Key Metrics
TTM PE Ratio | PB Ratio | Dividend Yield | Sector PE | Sector PB | Sector Div Yld |
5.87 | 6.27 | 19.48% | 36.68 | 6.58 | 0.82% |
Peers & Comparison
Stock | PE Ratio | PB Ratio | Dividend Yield |
Aster DM Healthcare Ltd | 5.87 | 6.27 | 19.48% |
Max Healthcare Institute Ltd | 117.30 | 15.01 | 0.12% |
Apollo Hospitals Enterprise Ltd | 75.11 | 14.84 | 0.37% |
Fortis Healthcare Ltd | 78.70 | 7.12 | 0.12% |
Is Aster DM Healthcare stock good to buy? (bull case & bear case)

Bull Case:
- Its business is growing quickly, with 29% yearly growth and better profit margins
- The company announced a big special dividend and regularly pays out 63.8% of its profits as dividends
- It now takes only 22.7 days to collect payments from customers, down from 110 days earlier
- Sold 65% of its Gulf business for $1 billion to focus on India and return money to shareholders
- Planning to add 3,300 more hospital beds by FY27, which will help it grow further
- The stock price has gone up by over 300% in the last 5 years, showing strong investor interest
Bear Case:
- The stock is expensive, trading at 9.23 times its book value and more than 100 times its earnings
- Promoters reduced their stake by 1.50% last quarter, and 40.7% of their holding is pledged as collateral
- Sales have fallen by 13.7% over the past 5 years, which is a concern
Conclusion
It is a fast-growing healthcare company that runs hospitals, clinics, pharmacies, and online health services in India and the Middle East. It recently sold part of its business in the Gulf for $1 billion to focus more on growing in India. The company is doing well by collecting payments faster and giving good returns to its shareholders through dividends. It also plans to add more hospital beds and use modern technology like robots and online tools to improve care.